Importation Of Usa-authorized Carbamazepine Extended-release Tablets, Usp 200 Mg And 400 Mg Due To The Current Shortage Of Canadian-authorized Carbamazepine
Recall Summary Health Canada is allowing the importation of US-authorized Carbamazepine Extended-Release Tablets (200 mg and 400 mg) into Canada due to a shortage of the Canadian-authorized version. These tablets are being distributed across Canada to address the supply gap. The US-authorized products have different labelling than the Canadian versions, which is why this temporary importation measure requires notification.
- Product
- Carbamazepine Extended-Release Tablets, USP 200 mg and 400 mg
- Reason
- Labelling - Supply - Product safety
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2024-06-05
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/117e49f6-0bca-4b36-a511-871ad9724dbc